As a key research-orientated player in the global consumer health market, Bayer fell to third place in 2009 as it was overtaken by rival GlaxoSmithKline. With competitors and the trading environment threatening sales growth, Euromonitor International analyses Bayer’s future prospects by region and category.
Euromonitor International’s Bayer AG in Consumer Health company profile offers detailed strategic analysis of the company’s business, examining its performance in the consumer healthcare industry. The report examines company shares by region and sector, product developments, market and distribution strategies, challenges from the competition and future prospects. Use it to understand opportunities and threats facing the business and the factors driving success.
Why buy this report? - Get a detailed picture of the consumer health industry; - Pinpoint growth sectors and identify factors driving change; - Understand the competitive environment, the market’s major players and leading brands; - Use five-year forecasts to assess how the market is predicted to develop.
